Graphene and 2D Materials for Healthcare
Guest edited by Laura Ballerini, Alberto Bianco, Kostas Kostarelos and Maurizio Prato
Over the past decade, the Graphene Flagship Division II (Health, Medicine, Sensors) has contributed immensely to developments in graphene-based technologies for biomedical applications, safe and sustainable graphene and related materials, and high-performance sensors with a variety of applications, from detecting disease biomarkers, to piezoresistive devices for microphones and speakers. This collection coincides with the celebration of the achievements and completion of this programme of work.
All of the articles in the collection are free to access until the 10 June 2025.
Read some of the featured articles below:
Emergence of graphene as a novel nanomaterial for cardiovascular applications
Paniz Memarian, Zohreh Bagher, Sheida Asghari, Mina Aleemardani and Alexander Seifalian
Nanoscale, 2024,16, 12793-12819
DOI: 10.1039/D4NR00018H
Biocomposites of 2D layered materials
Mert Vural and Melik C. Demirel
Nanoscale Horiz., 2025,10, 664-680
DOI: 10.1039/D4NH00530A
Efficient skin interactions of graphene derivatives: challenge, opportunity or both?
Fatemeh Zabihi, Zhaoxu Tu, Sabine Kaessmeyer, Fabian Schumacher, Fiorenza Rancan, Burkhard Kleuser, Christoph Boettcher, Kai Ludwig,f Johanna Plendl, Sarah Hedtrich, Annika Vogt and Rainer Haag
Nanoscale Adv., 2023,5, 5923-5931
DOI: 10.1039/D3NA00574G
Our nanoscience journals are always interested in considering high-quality articles on graphene and 2D materials and we would be delighted if you would consider the journal for your next submission, which can be made via our online submission service. All submissions will be subject to initial assessment and peer review as appropriate according to the respective journal’s guidelines.
We hope you enjoy reading this collection and look forward to seeing how this field progresses! Please continue to submit your exciting work on graphene and 2D materials to Nanoscale Horizons, Nanoscale and Nanoscale Advances.